[LCID Study Number: 20193042]

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects with Multiple System Atrophy (M-STAR Study)

The purpose of this Phase 3 study is to demonstrate the efficacy of BHV-3241 in the
treatment of MSA and characterize its safety/tolerability profile.

Primary Contact Email: [email protected]

Primary Contact Phone: (781) 744-8383